Core Viewpoint - Growth investors are increasingly focused on stocks with above-average financial growth, and Boston Scientific (BSX) is highlighted as a strong candidate due to its favorable growth metrics and Zacks Rank [2][10] Earnings Growth - Boston Scientific has a historical EPS growth rate of 17.6%, with projected EPS growth of 15.8% for the current year, surpassing the industry average of 12.5% [4] Cash Flow Growth - The company exhibits a year-over-year cash flow growth of 26.5%, significantly higher than the industry average of -8.8% [5] - Over the past 3-5 years, Boston Scientific's annualized cash flow growth rate has been 9.9%, compared to the industry average of 7.9% [6] Earnings Estimate Revisions - There have been upward revisions in current-year earnings estimates for Boston Scientific, with the Zacks Consensus Estimate increasing by 2.2% over the past month [8]

JR Research is an opportunistic investor. He was recognized by TipRanks as a Top Analyst. He was also recognized by Seeking Alpha as a "Top Analyst To Follow" for Technology, Software, and Internet, as well as for Growth and GARP. He identifies attractive risk/reward opportunities supported by robust price action to potentially generate alpha well above the S&P 500. He has also demonstrated outperformance with his picks. He focuses on identifying growth investing opportunities that present the most attracti ...

Core Insights - Zacks Premium provides tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1][2] Zacks Style Scores - Zacks Style Scores are indicators that rate stocks based on value, growth, and momentum characteristics, helping investors identify stocks likely to outperform the market in the next 30 days [2][3] - Each stock is rated from A to F, with A indicating the highest potential for outperformance [3] Value Score - The Value Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow [3] Growth Score - The Growth Score assesses a company's future prospects by analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - The Momentum Score evaluates stocks based on price trends and earnings outlook, utilizing one-week price changes and monthly earnings estimate changes [5] VGM Score - The VGM Score combines the three Style Scores to identify stocks with attractive value, strong growth forecasts, and promising momentum [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to guide investors in building successful portfolios [7] - Stocks rated 1 (Strong Buy) have historically produced an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] Investment Strategy - For optimal returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [9] - Stocks with lower ranks but high Style Scores may still present risks if earnings forecasts are declining [10] Company Spotlight: Paymentus (PAY) - Paymentus is rated 2 (Buy) on the Zacks Rank with a VGM Score of B, indicating strong potential for momentum investors [11] - The company has seen a 5.9% increase in shares over the past four weeks, with a consensus earnings estimate of $0.58 per share for fiscal 2025 [12] - Paymentus has an average earnings surprise of 33.3%, making it a strong candidate for investors [12]

Core Insights - JR Research is recognized as a top analyst in technology, software, and internet sectors, focusing on growth and GARP strategies [1] - The investment approach emphasizes identifying attractive risk/reward opportunities with robust price action to generate alpha above the S&P 500 [1][2] - The investment group Ultimate Growth Investing specializes in high-potential opportunities across various sectors with a focus on strong growth potential and contrarian plays [3] Investment Strategy - The strategy combines sharp price action analysis with fundamentals investing, avoiding overhyped stocks while targeting battered stocks with recovery potential [2] - The investment outlook is typically 18 to 24 months for the thesis to materialize, aiming for robust fundamentals and attractive valuations [3] Target Audience - The group is designed for investors looking to capitalize on growth stocks with strong fundamentals, buying momentum, and turnaround plays [3]

He tends to avoid overhyped and overvalued stocks while capitalizing on battered stocks with significant upside recovery possibilities. JR Research is an opportunistic investor. He was recognized by TipRanks as a Top Analyst. He was also recognized by Seeking Alpha as a "Top Analyst To Follow" for Technology, Software, and Internet, as well as for Growth and GARP. He identifies attractive risk/reward opportunities supported by robust price action to potentially generate alpha well above the S&P 500. He has ...

Core Insights - JR Research is recognized as a top analyst in technology, software, and internet sectors, focusing on growth and GARP strategies [1] - The investment approach emphasizes identifying attractive risk/reward opportunities with robust price action to generate alpha above the S&P 500 [1][2] - The investment group Ultimate Growth Investing specializes in high-potential opportunities across various sectors with a focus on strong growth potential and contrarian plays [3] Investment Strategy - The strategy combines sharp price action analysis with fundamentals investing, avoiding overhyped stocks while targeting battered stocks with recovery potential [2] - The investment outlook is typically 18 to 24 months for the thesis to materialize, aiming for robust fundamentals and attractive valuations [3] Target Audience - The group is designed for investors looking to capitalize on growth stocks with strong fundamentals, buying momentum, and turnaround plays [3]

Core Insights - JR Research is recognized as a top analyst in technology, software, and internet sectors, focusing on growth and GARP strategies [1] - The investment approach emphasizes identifying attractive risk/reward opportunities with robust price action to generate alpha above the S&P 500 [1][2] - The investment group Ultimate Growth Investing specializes in high-potential opportunities across various sectors with a focus on strong growth potential and contrarian plays [3] Investment Strategy - The strategy combines sharp price action analysis with fundamentals investing, avoiding overhyped stocks while targeting battered stocks with recovery potential [2] - The investment outlook is typically 18 to 24 months for the thesis to materialize, aiming for robust fundamentals and attractive valuations [3] Target Audience - The group is designed for investors looking to capitalize on growth stocks with strong fundamentals, buying momentum, and turnaround plays [3]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying stocks that can fulfill their growth potential is challenging [1] Group 1: Company Overview - Xylem (XYL) is highlighted as a recommended growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company operates in the water and wastewater treatment sector, which is currently positioned for growth [3] Group 2: Earnings Growth - Xylem has a historical EPS growth rate of 15%, with projected EPS growth of 9.2% this year, surpassing the industry average of 7.7% [4] - Double-digit earnings growth is preferred by growth investors as it indicates strong future prospects [3] Group 3: Cash Flow Growth - Xylem's year-over-year cash flow growth is 27.1%, significantly higher than the industry average of 8.8% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 11%, compared to the industry average of 10.4% [6] Group 4: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Xylem, with a 0.2% increase in the Zacks Consensus Estimate for the current year over the past month [7] Group 5: Investment Positioning - Xylem has earned a Growth Score of B and a Zacks Rank 2 due to positive earnings estimate revisions, positioning it well for potential outperformance [9]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates can be challenging due to inherent volatility and risks [1] Group 1: Company Overview - Marvell Technology (MRVL) is highlighted as a recommended growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 16.4%, with projected EPS growth of 75.6% this year, significantly outperforming the industry average of 23.9% [5] Group 2: Financial Metrics - Marvell's year-over-year cash flow growth stands at 3.2%, surpassing the industry average of -7.5% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 22.1%, compared to the industry average of 10.4% [7] Group 3: Earnings Estimates - There is a positive trend in earnings estimate revisions for Marvell, with the current-year earnings estimates increasing by 0.6% over the past month [8] - Marvell has achieved a Growth Score of B and a Zacks Rank 2, indicating positive earnings estimate revisions [9] Group 4: Investment Potential - The combination of a strong Growth Score and Zacks Rank suggests that Marvell is a potential outperformer and a solid choice for growth investors [10]

The group is designed for investors seeking to capitalize on growth stocks with robust fundamentals, buying momentum, and turnaround plays at highly attractive valuations. Learn more He focuses on identifying growth investing opportunities that present the most attractive risk/reward upside potential. His approach combines sharp price action analysis with fundamentals investing. He tends to avoid overhyped and overvalued stocks while capitalizing on battered stocks with significant upside recovery possibili ...